IVF add-on may be expensive, invasive, and ineffective, study finds

One of the most common add-ons to IVF procedures undertaken in Australia and globally by infertile couples may be a waste of time as well as expensive and invasive, and may even reduce the chances of success, according to a new report in The Lancet.

BU professor receives NIH grant to study impact of PFAS toxicants on the vascular system

Noyan Gokce, MD, professor of medicine at Boston University Chobanian & Avedisian School of Medicine, has been awarded a $453,750 National Institutes of Health (NIH)

July 15, 2023

Amphastar Pharmaceuticals Completes Acquisition of BAQSIMI® from Lilly – Biotech Investments

Rancho Cucamonga, 06/30/2023 / 13:05, PST/PDT – EQS Newswire – Amphastar Pharmaceuticals, Inc. RANCHO CUCAMONGA, CA / ACCESSWIRE / June 30, 2023 / Amphastar Pharmaceuticals,

July 1, 2023

Power Secures $11.9M to Democratize Clinical Trials

What You Should Know: – Power, the company transforming the traditional clinical trial landscape, announced today the close of their $11.9M Series A funding round

February 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.